Cargando…
Problems for risk assessment of endocrine-active estrogenic compounds.
Estrogenic industrial compounds such as bisphenol A (BPA) and nonylphenol typically bind estrogen receptor (ER) alpha and ERBeta and induce transactivation of estrogen-responsive genes/reporter genes, but their potencies are usually greater than or equal to 1,000-fold lower than observed for 17Beta-...
Autores principales: | Safe, Stephen H, Pallaroni, Lea, Yoon, Kyungsil, Gaido, Kevin, Ross, Susan, McDonnell, Donald |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241274/ https://www.ncbi.nlm.nih.gov/pubmed/12634121 |
Ejemplares similares
-
Recent advances in understanding endocrine disruptors: DDT and related compounds
por: Safe, Stephen
Publicado: (2020) -
Endocrine disruptors and human health--is there a problem? An update.
por: Safe, S H
Publicado: (2000) -
Environmental and dietary estrogens and human health: is there a problem?
por: Safe, S H
Publicado: (1995) -
Comparative estrogenic activity of wine extracts and organochlorine pesticide residues in food.
por: Gaido, K, et al.
Publicado: (1998) -
Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes
por: Lizcano, Fernando
Publicado: (2022)